University of Health Sciences GOP Training and Research Hospital
Istanbul, Gaziosmanpasa, 34020, Turkey (Türkiye)
NCT Number: NCT07765784
This prospective cross-sectional study examined the relationship between placental weight and early neonatal outcomes, such as blood glucose levels within the first 24 hours and early neonatal morbidities in infants born to mothers with gestational diabetes. levels in the first 24 hours of life and early neonatal morbidities, in infants born to mothers with gestational diabetes.
Looking for future studies?
Notify Me0 hour–2 day
All sexes
Observational
Istanbul, Gaziosmanpasa, 34020, Turkey (Türkiye)
This prospective cross-sectional study investigated the association between placental weight and early neonatal outcomes, including blood glucose levels within the first 24 hours and early neonatal morbidities in infants born to mothers with gestational diabetes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood glucose levels of the infants enrolled in the study were checked at the first 30 minutes after birth and at the end of 1,2, 6,24 hours of life.
Time frame: 8 months
If the infants had a blood glucose level below the predefined limits, they would be included in the hypoglycemia group.
Kanuni Sultan Suleyman Training and Research Hospital
Other
Placental Weight and Placental Weight-to-Birth Weight Ratio as Predictors of Early Neonatal Glycemic Profiles in Infants Born to Mothers With Gestational Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07015970
Autoimmune Diseases, Diabetes Mellitus
Caen, France
View Trial DetailsNCT05470842
Diabetes, Diabetes Mellitus
Norwich, Norfolk, United Kingdom
View Trial DetailsNCT01922817
Autoimmune Diseases, Diabetes Mellitus
Dundee, United Kingdom
View Trial DetailsNCT02341313
Glucose Metabolism Disorders, Hypoglycaemia
Cambridge, United Kingdom
View Trial Details